BIIB - biogen.com Operating profit before depreciation charges

Public company logo of biogen.com (BIIB)

High R&D expenditures and the risks associated with developing Alzheimer's drugs create volatility, as demonstrated by the EBITDA history. The value of 2602.47 captures the current state of the parameter. Biogen Inc. (BIIB) is implementing breakthrough treatments for rare pathologies, pivoting its business from the multiple sclerosis market toward global innovative neurological drugs to save millions of people.

biogen.com (BIIB) Profit before payment of interest, taxes and amortization: for the period 11/23/2025 - 11/10/2026
Brand item of Biogen Corp

This indicator is calculated as the sum of operating income minus variable costs. This metric measures actual cash flow, excluding the impact of depreciation and debt service. For Biogen Inc. (BIIB), this is critical when assessing the costs of high-risk clinical trials. The trend of the EBITDA financial metric allows for the timely detection of declining profitability due to patent expirations. Analyzing this chart helps avoid overpaying for the asset.

Who Biogen Inc. competes with

Neurocrine Corp (NBIX) - Profit before interest, taxes and amortization|Regencell Bioscience - Operating profit EBITDA|Operating profit before depreciation charges axsome.com (AXSM)|ACAD: Operating profit EBITDA|Profit before interest, taxes and amortization Xenon Pharmaceuticals Inc. (XENE)|Profit before payment of interest, taxes and amortization Viking Pharma|Operating profit before amortization SUPN (Supernus Corp)|Operating profit before deduction of amortization CPRX (Catalyst Pharmaceuticals)|DNLI (denalitherapeutics.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA HRMY (Harmony Biosciences Holdings, Inc.)|Operating income before deduction of amortization Biohaven Ltd (BHVN)|AMLX - Profit before payment of interest, taxes and amortization|TRVI (Trevi Corp) - Operating profit before amortization|PRAX: Operating profit EBITDA|Operating profit before deduction of amortization anavex.com|Operating profit before deduction of amortization CBLL|Prothena Corporation PLC (PRTA) - Operating income before deduction of amortization|Operating profit EBITDA ALEC|Profit before payment of interest, taxes and amortization ANNX (Annexon Biosciences Inc.)|Operating profit EBITDA OMER (Omeros)|Operating income before deduction of amortization neurogene.com (NGNE)|AC Immune SA - Operating profit EBITDA|Operating income before deduction of amortization Voyager Therapeutics Inc VYGR|NMRA: Operating profit EBITDA|SCLX (Scilex Holding Company, Inc.) - Profit before payment of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Tevogen Bio Holdings|Operating profit before amortization ACOG (Alpha Cognition Corp)|Operating profit EBITDA CGTX|IKT - Profit before interest, taxes and amortization|Cassava - Operating profit before deduction of amortization|Operating profit EBITDA Assertio Holdings ASRT|COYA - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization VTGN (Vistagen Therapeutics)|ovidrx.com (OVID) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Acumen Pharmaceuticals Inc. (ABOS)|CRVO (CervoMed Inc) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization ATHE|Operating profit EBITDA CLNN|Operating income before deduction of amortization pepgen.com|Profit before payment of interest, taxes and amortization Jupiter Neurosciences JUNS|Relmada Therapeutics Inc (RLMD) - Profit before interest, taxes and amortization|Annovis Bio Corp - Operating profit EBITDA|Operating profit before depreciation charges Grace Therapeutics, Inc. (GRCE)|AIFF: Operating profit EBITDA|Profit before interest, taxes and amortization Klotho Neurosciences (KLTO)|Profit before payment of interest, taxes and amortization NeuroSense Therapeutics Ltd|Operating profit before amortization RVPH (Reviva Pharmaceuticals Holdings Inc.)|Operating profit before deduction of amortization MTVA (MetaVia Inc)|NRXS (NeurAxis Inc) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA HSDT (Helius Medical Technologies)|Operating income before deduction of amortization Passage Bio Inc. (PASG)|NEUP - Profit before payment of interest, taxes and amortization|NERV (Minerva Neurosciences Inc) - Operating profit before amortization|ATHA: Operating profit EBITDA|Operating profit before deduction of amortization Addex|Operating profit before deduction of amortization ALZN|Cyclerion (CYCN) - Operating income before deduction of amortization|Operating profit EBITDA PTIX|Profit before payment of interest, taxes and amortization KTTA (pasitheaclinics.com)|Operating profit EBITDA CRGT (Cortigent)|Operating income before deduction of amortization Avenue Therapeutics Inc (ATXI)|Brainstorm Cell - Operating profit EBITDA|Operating income before deduction of amortization caratherapeutics.com CARA|CHRO: Operating profit EBITDA|ELYM (Eliem Therapeutics Inc.) - Profit before payment of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Intra-Cellular Therapies Inc.|Operating profit before amortization LBPH (Longboard)|Operating profit EBITDA MRNS|NKGN - Profit before interest, taxes and amortization|NeuroBo Pharmaceuticals, Inc. - Operating profit before deduction of amortization|Operating profit EBITDA Sage Therapeutics Inc. SAGE|SNPX - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization TRVN (Trevena Inc)|vigilneuro.com (VIGL) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization anewmeds.com (WENA)|CERE (Cerevel Therapeutics, Inc.) - Operating profit EBITDA